NCI-BL1437細胞
生長狀態： 懸浮生長
ATCC Number： CRL-5958?
器官來源： 外周血
運輸方式： 凍存運輸
年限： 60 years
細胞類型： B**細胞
細胞形態： **樣
是否是腫瘤細胞： 0
物種來源： 人
數量： 大量
Designations: NCI-BL1437 [BL1437]
NCI-BL1437細胞Depositors: AF Gazdar, JD Minna
Biosafety Level: 2 [Cells Contain Epstein Barr Virus (EBV) a Herpesvirus ]
Shipped: frozen
Medium & Serum: See Propagation
Growth Properties: suspension
Organism: Homo sapiens
Morphology: lymphoblast
Source: Organ: peripheral blood
Cell Type: B lymphoblast; Epstein-Barr virus (EBV) transformed
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Restrictions: NCI-BL1437細胞The line is available with the following restrictions: 1. This cell line was deposited at the ATCC by Dr. A. Gazdar and Dr. J. Minna and is provided for research purposes only. Neither the cell line nor products derived from it may be sold or used for commercial purposes. Nor can the cells be distributed to third parties for purposes of sale, or producing for sale, cells or their products. The cells are provided as service to the research community. They are provided without warranty of merchantability or fitness for a particular purpose or any other warranty, expressed or implied. 2. Any proposed commercial use of the these cells, or their products must first be negotiated with the University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd., Dallas, Texas 75235. Telephone (214) 699-8056, FAX (214) 688-7233.
DNA Profile (STR): Amelogenin: X,Y
CSF1PO: 11,12
D13S317: 12
D16S539: 11,12
D5S818: 11,14
D7S820: 8,11
THO1: 6,8
TPOX: 9,10
vWA: 17,18
Age: 60 years
Gender: male
Ethnicity: Caucasian
Comments: NCI-BL1437細胞A lung adenocarcinoma cell line from this patient is available as ATCC CRL-5872.
Propagation: ATCC complete growth medium: HITES medium supplemented with 5% fetal bovine serum
The base medium for this cell line is ATCC-formulated DMEM:F12 Medium Catalog No.30-2006. To make the complete growth medium,add the following components to the base medium
0.005 mg/ml Insulin
0.01 mg/ml Transferrin
30nM Sodium selenite (final conc.)
10 nM Hydrocortisone (final conc.)
10 nM beta-estradiol (final conc.)
extra 2mM L-glutamine (for final conc. of 4.5 mM)
5% fetal bovine serum (final conc.)
Temperature: 37.0°C
Subculturing: Cultures can be maintained by addition of fresh medium orreplacement of medium. Alternatively, cultures can beestablished by centrifugation with subsequent resuspension in fresh medium at 2- 5 x 10 exp5 viable cells/ml.
Maintain cell density between 1 X 10 exp5 and 1 X 10 exp6 viable cells/ml.
Preservation: Culture medium, 95%; DMSO, 5%
Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2006
tumor cell line established from the same patient:ATCC CRL-5872
References: 23570: . NCI-BL1437細胞NCI-Navy Medical Oncology Branch Cell Line Supplement. J. Cell. Biochem. suppl. 24: 1996.
